Quisel
Principal executive officer pay for Quisel, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
Disc Medicine, Inc. (IRON) FY2022–FY2025
Beat peersTSR 299% vs peer group 35% over FY2022–FY2025
Turnaround$100 invested moved from behind the peer group ($64.58 vs $88.48) to ahead ($257.82 vs $119.85) over FY2022–FY2025
Aligned: paid up as stock roseCAP $1,183,878→$13,475,891 while $100 invested went $64.58→$257.82
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2022 | $1.8M | $1.2M |
| FY2023 | $909,100 | $5.2M |
| FY2024 | $9.1M | $8.7M |
| FY2025 | $10.0M | $13.5M |
The company's "$100 invested" index ran $64.58 at FY2022 → $257.82 by FY2025 — an annualized return of 58.6%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 58.6%/yr at IRON ( FY2022–FY2025). See the CEO track-record ranking for context.